These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11381003)

  • 21. Prescription drug advertising: trends and implications.
    Krupka LR; Vener AM
    Soc Sci Med; 1985; 20(3):191-7. PubMed ID: 3975684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug advertisements published in Indian Medical Journals: Are they ethical?
    Charan J; Yadav P; Saxena D; Kantharia ND
    J Pharm Bioallied Sci; 2011 Jul; 3(3):403-6. PubMed ID: 21966161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advertising in dermatology journals: journals' and journal editors' policies, practices, and attitudes.
    Bartus CL; Katz KA
    J Am Acad Dermatol; 2006 Jul; 55(1):116-22. PubMed ID: 16781302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of pharmaceutical advertisements in medical journals: a systematic review.
    Othman N; Vitry A; Roughead EE
    PLoS One; 2009 Jul; 4(7):e6350. PubMed ID: 19623259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug advertising in medical journals].
    Madridejos R; Cabezas C; Flor F
    Aten Primaria; 1996 Apr; 17(6):408-10. PubMed ID: 8672646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing information in drug advertisements.
    Holmes JD
    N Z Med J; 1977 Nov; 86(600):467-9. PubMed ID: 272555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical evaluation of references in drug advertisements: an Indian experience.
    Lal A; Moharana AK; Chandra P; Ray A
    J Assoc Physicians India; 1996 Nov; 44(11):778-9. PubMed ID: 9251451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of drug advertising in Spanish gynecology journals].
    Diez B; Hidalgo A
    Gac Sanit; 2012; 26(3):270-3. PubMed ID: 22088908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Claim validity of print advertisements found in otolaryngology journals.
    Del Signore A; Murr AH; Lustig LR; Platt MP; Jalisi S; Pratt LW; Spiegel JH
    Arch Otolaryngol Head Neck Surg; 2011 Aug; 137(8):746-50. PubMed ID: 21576549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug marketing in French-speaking African countries.
    Chirac P; Pikon A; Poinsignon Y; Vitry A
    Soc Sci Med; 1993 Jun; 36(12):1541-3. PubMed ID: 8327917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A content analysis of direct-to-consumer television prescription drug advertisements.
    Kaphingst KA; DeJong W; Rudd RE; Daltroy LH
    J Health Commun; 2004; 9(6):515-28. PubMed ID: 15764450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study.
    Diep D; Mosleh-Shirazi A; Lexchin J
    BMJ Open; 2020 Jul; 10(7):e034993. PubMed ID: 32690502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription drug advertising trends: a study of oral hypoglycemics.
    Mehta KK; Sorofman BA; Rowland CR
    Soc Sci Med; 1989; 29(7):853-7. PubMed ID: 2799427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?
    Woloshin S; Schwartz LM; Tremmel J; Welch HG
    Lancet; 2001 Oct; 358(9288):1141-6. PubMed ID: 11597668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.
    Davis JJ
    J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription drug advertising: is it a driving force on drug pricing?
    Millstein LG
    N C Med J; 2003; 64(6):289-91. PubMed ID: 14983621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How evidence-based are advertisements in journals regarding the subspecialty of rheumatology?
    van Winkelen P; van Denderen JS; Vossen CY; Huizinga TW; Dekker FW
    Rheumatology (Oxford); 2006 Sep; 45(9):1154-7. PubMed ID: 16531437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.